{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:33:16Z","timestamp":1791214396902,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,19]],"date-time":"2009-12-19T00:00:00Z","timestamp":1261180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00262-009-0807-3","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T14:26:26Z","timestamp":1261146386000},"page":"829-839","source":"Crossref","is-referenced-by-count":56,"title":["Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked"],"prefix":"10.1007","volume":"59","author":[{"given":"Marie","family":"von Lilienfeld-Toal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Leyendecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Feyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jarmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Glasmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"M\u00e4rten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo G. H.","family":"Schmidt-Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,19]]},"reference":[{"key":"807_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2141.2005.05534.x","volume":"130","author":"SJ Harrison","year":"2005","unstructured":"Harrison SJ, Cook G (2005) Immunotherapy in multiple myeloma\u2014possibility or probability? Br J Haematol 130:344\u2013362","journal-title":"Br J Haematol"},{"key":"807_CR2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/jlb.66.6.981","volume":"66","author":"G Cook","year":"1999","unstructured":"Cook G, Campbell JD, Carr CE, Boyd KS, Franklin IM (1999) Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes. J Leukoc Biol 66:981\u2013988","journal-title":"J Leukoc Biol"},{"key":"807_CR3","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","volume":"98","author":"RD Brown","year":"2001","unstructured":"Brown RD, Pope B, Murray A, Esdale W, Sze DM, Gibson J, Ho PJ, Hart D, Joshua D (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7\u20131) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood 98:2992\u20132998","journal-title":"Blood"},{"key":"807_CR4","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","volume":"107","author":"M Beyer","year":"2006","unstructured":"Beyer M, Kochanek M, Giese T, Endl E, Weihrauch MR, Knolle PA, Classen S, Schultze JL (2006) In vivo peripheral expansion of naive CD4+ CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood 107:3940\u20133949","journal-title":"Blood"},{"key":"807_CR5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12032-007-0007-y","volume":"24","author":"V Jurisic","year":"2007","unstructured":"Jurisic V, Srdic T, Konjevic G, Markovic O, Colovic M (2007) Clinical stage-depending decrease of NK cell activity in multiple myeloma patients. Med Oncol 24:312\u2013317","journal-title":"Med Oncol"},{"key":"807_CR6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.leu.2404096","volume":"20","author":"C Fauriat","year":"2006","unstructured":"Fauriat C, Mallet F, Olive D, Costello RT (2006) Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma. Leukemia 20:732\u2013733","journal-title":"Leukemia"},{"key":"807_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2004-04-1422","volume":"105","author":"E Carbone","year":"2005","unstructured":"Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V, Spies T, Pollio G, Cosman D et al (2005) HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 105:251\u2013258","journal-title":"Blood"},{"key":"807_CR8","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1158\/0008-5472.CAN-05-0731","volume":"65","author":"S Girlanda","year":"2005","unstructured":"Girlanda S, Fortis C, Belloni D, Ferrero E, Ticozzi P, Sciorati C, Tresoldi M, Vicari A, Spies T, Groh V et al (2005) MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes. Cancer Res 65:7502\u20137508","journal-title":"Cancer Res"},{"key":"807_CR9","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1158\/0008-5472.CAN-06-4230","volume":"67","author":"YM El-Sherbiny","year":"2007","unstructured":"El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE et al (2007) The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res 67:8444\u20138449","journal-title":"Cancer Res"},{"key":"807_CR10","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1182\/blood-2006-07-035519","volume":"109","author":"PK Epling-Burnette","year":"2007","unstructured":"Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, Zou J, Ku E, Zhong B, Boulware D et al (2007) Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood 109:4816\u20134824","journal-title":"Blood"},{"key":"807_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/1078-0432.CCR-06-1454","volume":"13","author":"T Osaki","year":"2007","unstructured":"Osaki T, Saito H, Yoshikawa T, Matsumoto S, Tatebe S, Tsujitani S, Ikeguchi M (2007) Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer. Clin Cancer Res 13:382\u2013387","journal-title":"Clin Cancer Res"},{"key":"807_CR12","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","volume":"172","author":"JC Lee","year":"2004","unstructured":"Lee JC, Lee KM, Kim DW, Heo DS (2004) Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172:7335\u20137340","journal-title":"J Immunol"},{"key":"807_CR13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419:734\u2013738","journal-title":"Nature"},{"key":"807_CR14","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4049\/jimmunol.171.12.6891","volume":"171","author":"ES Doubrovina","year":"2003","unstructured":"Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O\u2019Reilly RJ, Dupont B, Vyas YM (2003) Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol 171:6891\u20136899","journal-title":"J Immunol"},{"key":"807_CR15","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1182\/blood-2003-01-0019","volume":"102","author":"HR Salih","year":"2003","unstructured":"Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A (2003) Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102:1389\u20131396","journal-title":"Blood"},{"key":"807_CR16","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/ijc.22186","volume":"119","author":"A M\u00e4rten","year":"2006","unstructured":"M\u00e4rten A, von Lilienfeld-Toal M, Buchler MW, Schmidt J (2006) Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity. Int J Cancer 119:2359\u20132365","journal-title":"Int J Cancer"},{"key":"807_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clim.2006.11.007","volume":"123","author":"V Rebmann","year":"2007","unstructured":"Rebmann V, Schutt P, Brandhorst D, Opalka B, Moritz T, Nowrousian MR, Grosse-Wilde H (2007) Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Clin Immunol 123:114\u2013120","journal-title":"Clin Immunol"},{"key":"807_CR18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0711293105","volume":"105","author":"M Jinushi","year":"2008","unstructured":"Jinushi M, Vanneman M, Munshi NC, Tai YT, Prabhala RH, Ritz J, Neuberg D, Anderson KC, Carrasco DR, Dranoff G (2008) MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc Natl Acad Sci USA 105:1285\u20131290","journal-title":"Proc Natl Acad Sci USA"},{"key":"807_CR19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2141.2007.06873.x","volume":"139","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Rajkumar SV (2007) Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol 139:730\u2013743","journal-title":"Br J Haematol"},{"key":"807_CR20","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood-2001-12-0297","volume":"100","author":"AC Rawstron","year":"2002","unstructured":"Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ (2002) Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood 100:3095\u20133100","journal-title":"Blood"},{"key":"807_CR21","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/eji.200425418","volume":"34","author":"C Vitale","year":"2004","unstructured":"Vitale C, Chiossone L, Cantoni C, Morreale G, Cottalasso F, Moretti S, Pistorio A, Haupt R, Lanino E, Dini G et al (2004) The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and\/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol 34:3028\u20133038","journal-title":"Eur J Immunol"},{"key":"807_CR22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.21382","volume":"118","author":"S Holdenrieder","year":"2006","unstructured":"Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR (2006) Soluble MICA in malignant diseases. Int J Cancer 118:684\u2013687","journal-title":"Int J Cancer"},{"key":"807_CR23","first-page":"4","volume":"4","author":"J Sugita","year":"2009","unstructured":"Sugita J, Tanaka J, Yasumoto A, Shiratori S, Wakasa K, Kikuchi M, Shigematsu A, Kondo T, Asaka M, Imamura M (2009) Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8(+) T cells. Ann Hematol 4:4","journal-title":"Ann Hematol"},{"key":"807_CR24","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.4049\/jimmunol.176.8.5108","volume":"176","author":"N Boissel","year":"2006","unstructured":"Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, Rousselot P, Tamouza R, Le Bouteiller P, Mahon FX et al (2006) BCR\/ABL oncogene directly controls MHC class I chain-related molecule. A expression in chronic myelogenous leukemia. J Immunol 176:5108\u20135116","journal-title":"J Immunol"},{"key":"807_CR25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.176.3.1490","volume":"176","author":"SJ Burgess","year":"2006","unstructured":"Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE (2006) IL-21 down-regulates NKG2D\/DAP10 expression on human NK and CD8\u00a0+\u00a0T cells. J Immunol 176:1490\u20131497","journal-title":"J Immunol"},{"key":"807_CR26","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"HG Kopp","year":"2009","unstructured":"Kopp HG, Placke T, Salih HR (2009) Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 69:7775\u20137783","journal-title":"Cancer Res"},{"key":"807_CR27","first-page":"354","volume":"82","author":"B Suarez-Alvarez","year":"2006","unstructured":"Suarez-Alvarez B, Lopez-Vazquez A, Diaz-Molina B, Bernardo-Rodriguez MJ, Alvarez-Lopez R, Pascual D, Astudillo A, Martinez-Borra J, Lambert JL, Gonzalez S et al (2006) The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection. Transplantation 82:354\u2013361","journal-title":"Transplantation"},{"key":"807_CR28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4049\/jimmunol.175.2.720","volume":"175","author":"K Wiemann","year":"2005","unstructured":"Wiemann K, Mittrucker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A (2005) Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol 175:720\u2013729","journal-title":"J Immunol"},{"key":"807_CR29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni1239","volume":"6","author":"DE Oppenheim","year":"2005","unstructured":"Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC (2005) Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6:928\u2013937","journal-title":"Nat Immunol"},{"key":"807_CR30","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.4049\/jimmunol.181.10.6711","volume":"181","author":"M Kloss","year":"2008","unstructured":"Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR (2008) Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J Immunol 181:6711\u20136719","journal-title":"J Immunol"},{"key":"807_CR31","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2008-06-165944","volume":"113","author":"C Cerboni","year":"2009","unstructured":"Cerboni C, Ardolino M, Santoni A, Zingoni A (2009) Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. Blood 113:2955\u20132964","journal-title":"Blood"},{"key":"807_CR32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CJI.0b013e3181755deb","volume":"31","author":"JY Kim","year":"2008","unstructured":"Kim JY, Bae JH, Lee SH, Lee EY, Chung BS, Kim SH, Kang CD (2008) Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. J Immunother 31:475\u2013486","journal-title":"J Immunother"},{"key":"807_CR33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/leu.2008.354","volume":"23","author":"A Poggi","year":"2009","unstructured":"Poggi A, Catellani S, Garuti A, Pierri I, Gobbi M, Zocchi MR (2009) Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia 23:641\u2013648","journal-title":"Leukemia"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0807-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-009-0807-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0807-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:33:22Z","timestamp":1558715602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-009-0807-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,19]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s00262-009-0807-3","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,19]]}}}